NEPA medical facilities receiving COVID-19 drug remdesivir

A sign is posted in front of the Gilead Sciences headquarters on April 29, 2020 in Foster City, California. Gilead Sciences announced preliminary results of remdesivir trial
Photo credit Justin Sullivan / Staff Getty Images News Getty Images North America

51 medical facilities across the state including several in NEPA will receive remdesivir.  They include Lehigh Valley Hazleton, Geisinger Wyoming Valley in Plains Township and Wilkes Barre General along with Geisinger community Medical Center and Regional Hospital of Scranton. The antiviral drug is being used to treat COVID 19 patients.